Results 111 to 120 of about 2,851 (168)

IL-6 and IL-18 cytokine traps in COVID-19

Инфекция и иммунитет
Cytokines are mediators of immunity that regulate inflammation. Intensity of inflammatory process is strongly dependent on the cytokine type and duration of its effect.
A. A. Korotaeva, Elena V. Samoilova, D. A. Chepurnova, N. V. Pogosova, D. T. Kuchiev, F. N. Paleev   +5 more
doaj   +1 more source

Regulation of IL-18 binding protein by IFN-gamma [PDF]

, 2003
In this study we investigated the regulation of IL-18BPa by IFN-y in the context of colon cancer and human autoimmune diseases. IL-18BPa is a naturally occuring inhibitor that counteracts IL-18 bioactivity.
Paulukat, Jens
core  

The imbalance of IL-18/IL-18BP in patients with systemic juvenile idiopathic arthritis [PDF]

Acta Biochimica et Biophysica Sinica, 2013
Ou, Chen, Ningning, Shan, Xiaobo, Zhu, Yibiao, Wang, Peng, Ren, De'e, Wei, Ruopeng, Sun   +6 more
openaire   +2 more sources

Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette–Guérin [PDF]

, 2017
Agnes F. Lee, Alfred A. Chan, Delphine J. Lee, Junbao Yang, Leland J. Foshag, Maris S. Jones, Mark B. Faries, Peter A. Sieling, Romela Irene Ramos   +8 more
core   +1 more source

Serum IL-18 is a specific biomarker for Macrophage Activation Syndrome across several autoinflammatory diseases [PDF]

, 2015

core   +1 more source

IL-18 and IL-18BP in Amyotrophic Lateral Sclerosis

Frontiers in Immunology, 2013
Boraschi Diana, Bossu' Paola, Borroni Barbara, Siciliano Gabriele, Migliorini Paola, Italiani Paola, Giungato Paola   +6 more
openaire   +1 more source

The Potential Contribution of the IL-37/IL-18/IL-18BP/IL-18R Axis in the Pathogenesis of Sjögren's Syndrome. [PDF]

Int J Mol Sci
Parisis D, Sarrand J, Soyfoo M.
europepmc   +1 more source

Role of IL-18 in atopic asthma is determined by balance of IL-18/IL-18BP/IL-18R. [PDF]

J Cell Mol Med, 2018
Zhang H, Wang J, Wang L, Xie H, Chen L, He S.   +5 more
europepmc   +1 more source

Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease. [PDF]

Ann Rheum Dis, 2018
Gabay C, Fautrel B, Rech J, Spertini F, Feist E, Kötter I, Hachulla E, Morel J, Schaeverbeke T, Hamidou MA, Martin T, Hellmich B, Lamprecht P, Schulze-Koops H, Courvoisier DS, Sleight A, Schiffrin EJ.   +16 more
europepmc   +1 more source

Special Issue "Immunomodulatory Molecules in Cancer". [PDF]

Int J Mol Sci
Pantouris G.
europepmc   +1 more source